Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
et al: Drug repurposing of FDA compounds against -Glucosidase for the treatment of type 2 diabetes: insights from molecular docking and molecular dynamics simulations
For pharma manufacturers, the sudden popularity of GLP-1 drugs has placed increased strain on the medical supply chain and subsequent pressure to avoid bottle necks
Questa affinit quantificata da una costante di stabilit logaritmica pari a 16,44, un valore che supera di gran lunga quello di complessi simili e che giustifica la formazione spontanea del complesso GHK-Cu in ambiente fisiologico
This lack of benefit stands in contrast with the significant or nearly-significant reduction in macrovascular risk reported with liraglutide, semaglutide and exenatide [51,52,53], which also enhance signaling through the GLP-1 receptor [54]
Because high intracranial pressure appears to be very common in these diseases, relieving it could be a big deal
From a drug-development perspective, METRNL illustrates the limitations of receptor-centric paradigms
US$ 23.57
US$ 24.76
US$ 24.16
US$ 28.71
US$ 29.36
US$ 25.28
US$ 21.16
US$ 20.17
